Readability & Display

Unofficial consolidated textConsolidated 2026-01-01English

Article 87

Reproduced from official EUR-Lex 1/1/2026.

Official catalogue · non-binding

Related guidance (22)

Current English catalogue entries that refer to Article 87. Guidance is non-binding and kept separate from the regulation text.

Browse topics
MDCG 2019-15 rev.1Guidance notes for manufacturers of class I medical devicesDecember 2019
MDCG 2021-6 - rev.1Regulation (EU) 2017/745 – Questions & Answers regarding clinical investigationDecember 2023
MDCG 2020-10/1 rev.1 MDCG 2020-10/2 rev.1Guidance on safety reporting in clinical investigationsAppendix: Clinical investigation summary safety report formOctober 2022October 2022
MDCG 2021-3Questions and Answers on Custom-Made DevicesMarch 2021
MDCG 2021-13 rev.1Questions and answers on obligations and related rules for the registration in EUDAMED of actors other than manufacturers, authorised representatives and importers subject to the obligations of Article 31 MDR and Article 28 IVDRJuly 2021
MDCG 2021-1 rev.1Guidance on harmonised administrative practices and alternative technical solutions until EUDAMED is fully functionalMay 2021
MDCG 2019-16 rev.1Guidance on cybersecurity for medical devicesJuly 2020
MDCG 2020-3 rev.1Guidance on significant changes regarding the transitional provision under Article 120 of the MDR with regard to devices covered by certificates according to MDD or AIMDDNote to the reader: Due to technical issues, please disregard the document displayed from 7 September 2023 until 8 September 2023.September 2023
Show all 22 guidance documentsShow only the first 8
MDCG 2020-14Guidance for notified bodies on the use of MDSAP audit reports in the context of surveillance audits carried out under the Medical Devices Regulation (MDR)/In Vitro Diagnostic medical devices Regulation (IVDR)August 2020
MDCG 2019-7 - rev.1Guidance on article 15 of the medical device regulation (MDR) and in vitro diagnostic device regulation (IVDR) on a ‘person responsible for regulatory compliance’ (PRRC)December 2023
MDCG 2025–10Guidance on post-market surveillance of medical devices and in vitro diagnostic medical devicesDecember 2025
MDCG 2024-1Device Specific Vigilance Guidance (DSVG) TemplateJanuary 2024
MDCG 2024-1-1DSVG 01 on Cardiac ablationJanuary 2024
MDCG 2024-1-2DSVG 02 on Coronary stentsJanuary 2024
MDCG 2024-1-3DSVG 03 on Cardiac implantable electronic devices (CIEDs)January 2024
MDCG 2024-1-4DSVG 04 on Breast implantsJanuary 2024
MDCG 2024-1-5DSVG 05 on Urogynaecological Surgical Mesh Implants used for Pelvic Organ Prolapse repair and Stress Urinary IncontinenceJune 2024
MDCG 2023-3 rev.2Questions and Answers on vigilance terms and concepts as outlined in the Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746January 2025
MDCG 2022-21Guidance on Periodic Safety Update Report (PSUR) according to Regulation (EU) 2017/745December 2022
MDCG 2022-7Q&A on the Unique Device Identification system under Regulation (EU) 2017/745 and Regulation (EU)May 2022
MDCG 2021-19Guidance note integration of the UDI within an organisation’s quality management systemJuly 2021
MDCG 2021-25 rev.1Application of MDR requirements to "legacy devices" and to devices placed on the market prior to 26 May 2021 in accordance with Directives 90/385/EEC or 93/42/EECOctober 2024

Reader references